Abstract:The development of a sensing platform with high sensitivity and specificity, especially programmability and universal applicability, for the detection of clinically relevant molecules is highly valuable for disease monitoring and confirmation but remains a challenge. Here, for the first time, we introduce the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system into an immobilization-free electrochemical biosensing platform for sensitively and specifically detecting the disease-related nucleic acids and small molecules. In this strategy, a modular rolling circle amplification (RCA) is designed to transform and amplify the target recognition event into the universal trigger DNA strand that is used as the trigger to activate the deoxyribonuclease activity of CRISPR/Cas12a for further signal amplification. The cleavage of the target-activated blocker probe allows the methylene blue-labeled reporter probes to be captured by the reduced graphene oxide-modified electrode, leading to an obviously increased electrochemical signal. We only need to simply tune the sequence for target recognition in RCA components, and this strategy can be flexibly applied to the highly sensitive and specific detection of microRNAs, Parvovirus B19 DNA, and adenosine-5′-triphosphate and the calculated limit of detection is 0.83 aM, 0.52 aM, and 0.46 pM, respectively. In addition, we construct DNA logic circuits (YES, NOT, OR, AND) of DNA inputs to experimentally demonstrate the modularity and programmability of the stimuli-responsive RCA-CRISPR/Cas12a system. This work broadens the application of the CRISPR/Cas12a system to the immobilization-free electrochemical biosensing platform and provides a new thinking for developing a robust tool for clinical diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.1c00805?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.1c00805</a>.Chemicals and reagents; apparatus and measurements; native polyacrylamide gel electrophoresis; calculation of the effective surface area of the modified electrode; calculation of limit of detection; and additional figures and tables (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.1c00805/suppl_file/ac1c00805_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Cell-Free Synthetic Biosensors Based on CRISPR/Cas Mediated Cascade Signal Amplification for Precise RNA Detection

Synthetic biology-powered biosensors based on CRISPR/Cas mediated cascade signal amplification for precise RNA detection

A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

SHERLOCK: nucleic acid detection with CRISPR nucleases

Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

Unraveling the Influence of CRISPR/Cas13a Reaction Components on Enhancing Trans-Cleavage Activity for Ultrasensitive On-Chip RNA Detection.

Universal and Programmable Rolling Circle Amplification-CRISPR/Cas12a-Mediated Immobilization-Free Electrochemical Biosensor

Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer

A CRISPR-based and Post-Amplification Coupled SARS-CoV-2 Detection with a Portable Evanescent Wave Biosensor

An Ultrasensitive, One-Pot RNA Detection Method Based on Rationally Engineered Cas9 Nickase-Assisted Isothermal Amplification Reaction.

Signal-amplifying Biohybrid Material Circuits for CRISPR/Cas-based single-stranded RNA Detection

PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA

A Novel Label-Free Universal Biosensing Platform Based on CRISPR/Cas12a for Biomarker Detection

Portable 3D-Printed Apta-Biosensor for Sensitive Atp Detection Based on Hybridization Chain Reaction Amplification and Crispr/Cas12a

A CRISPR/Cas13a-powered catalytic hairpin assembly evanescent wave fluorescence biosensor for target amplification-free SARS-CoV-2 detection

Precise amplification-free detection of highly structured RNA with an enhanced SCas12a assay

A DNA-Cu Nanocluster and Exonuclease I Integrated Label-Free Reporting System for CRISPR/Cas12a-based SARS-CoV-2 Detection with Minimized Background Signals.

CRISPR/Cas13a Trans-Cleavage-Triggered Catalytic Hairpin Assembly Assay for Specific and Ultrasensitive SARS-CoV-2 RNA Detection

Designing a CRISPR/Cas12a- and Au-Nanobeacon-Based Diagnostic Biosensor Enabling Direct, Rapid, and Sensitive miRNA Detection